Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study
After 5 years of follow-up, there were no significant differences between the SG and OAGB groups with regard to T2DM remission and relapse. Bariatric surgery was less likely to result in remission in patients with a history of insulin therapy and longer durations of T2DM prior to surgery. Furthermore, patients who received ≥2 glucose-lowering agents, despite possible remission, were at a higher risk of experiencing late relapse.
Authors
- Amir Ebadinejad (ORCID: https://orcid.org/0000-0002-3147-6103)
- Majid Valizadeh (ORCID: https://orcid.org/0000-0002-3155-1951)
- Sara Sadeghi (ORCID: https://orcid.org/0000-0002-3405-6681)
- Farhad Hosseinpanah (ORCID: https://orcid.org/0000-0001-5235-9451)
- Maryam Barzin (ORCID: https://orcid.org/0000-0001-7718-1952)
- Maryam Mahdavi (ORCID: https://orcid.org/0000-0002-8371-0694)
- Alireza Khalaj (ORCID: https://orcid.org/0000-0001-5164-9406)
Institutions
- Shahed University (IR)
- Hartford Hospital (US)
- Kashan University of Medical Sciences (IR)
- Research Institute for Endocrine Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1111/dom.15974
- Citations
- 3
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Shahid Beheshti University of Medical Sciences